Editor's Picks

Articles

Latest
Most Viewed
Most Downloaded
Most Cited
Open Access Case Report
Multimodal physical therapy intervention based on a biobehavioral approach in a patient with chronic upper limb pain: a case report
Chronic upper limb pain is rather common among people in general and is characterized by a complex diagnosis due to the wide variety of factors that are involved in its development. In terms of trea
Published: April 26, 2025 Explor Neuroprot Ther. 2025;5:1004102
64 7 0
Open Access Review
Therapeutic effect of erythropoietin and its derivatives in the treatment of acute ischemic stroke
Stroke is the third leading cause of death and disability in industrialized countries. The estimated costs of stroke to the healthcare system are $85 billion in the United States and $40 billion in
Published: April 24, 2025 Explor Neuroprot Ther. 2025;5:1004101
115 7 0
Open Access Review
Role of dopamine receptor heteromerization in preclinical models of addiction and other psychiatric disorders
Similar to other psychiatric disorders, drug addiction is linked to changes in neuronal activity within the mesolimbic system, which consists of dopamine (DA) neurons of the ventral tegmental area p
Published: April 01, 2025 Explor Neuroprot Ther. 2025;5:1004100
428 17 0
Open Access Original Article
Neurophysiological findings in Attention Deficit Hyperactivity Disorder, a Pandora’s box with therapeutic implications
Aim: Growing evidence suggests that Attention Deficit Hyperactivity Disorder (ADHD) may not be a single entity with a universal remedy, but rather a group of conditions resulting from interactive
Published: March 30, 2025 Explor Neuroprot Ther. 2025;5:100499
443 14 0
Open Access Review
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Neurodegenerative diseases are a complex ensemble of ailments characterized by progressive neuronal deterioration and ultimate loss, resulting in drastic impairments of memory, cognition and other b
Published: March 09, 2025 Explor Neuroprot Ther. 2025;5:100498
667 18 0
Open Access Original Article
CE(20:4) and CE(22:5) cholesteryl ester levels are elevated in the plasma of Alzheimer’s disease patients with ε3/ε4 genotype
Aim: This study investigates the association between ApoE genotype, plasma cholesteryl ester (CE) levels, and Alzheimer’s disease (AD) status, with a focus on CE(20:4) and CE(22:5) levels as po
Published: February 24, 2025 Explor Neuroprot Ther. 2025;5:100497
463 11 0
Open Access Review
Balancing cholesterol in the brain: from synthesis to disposal
The cholesterol is a vital component of cell membranes and myelin sheaths, and a precursor for essential molecules such as steroid hormones. In humans, cholesterol is partially obtained through the
Published: January 05, 2022 Explor Neuroprot Ther. 2022;2:1–27
12803 446 11
Open Access Review
Biomarkers in small fiber neuropathy
Small fiber neuropathy (SFN) is a relatively common, but largely understudied neurological syndrome which has affected the lives of many globally. The common symptoms of SFN include pain, dysesthesi
Published: December 30, 2022 Explor Neuroprot Ther. 2022;2:264–283
10701 142 2
Open Access Review
Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration
Depression is a known risk factor for dementia. Antidepressants are the most commonly used treatment for this condition, and are effective in at least half to two-thirds of cases. Extensive evidence
Published: February 23, 2024 Explor Neuroprot Ther. 2024;4:11–37
10324 97 2
Open Access Review
Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Phosphoinositides are membrane phospholipids involved in a variety of cellular processes like growth, development, metabolism, and transport. This review focuses on the maintenance of cellular homeo
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86–110
10252 329 30
Open Access Review
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting 1% of the population above sixty years. It is caused by an interaction between genetic and envi
Published: February 27, 2023 Explor Neuroprot Ther. 2023;3:24–46
9707 247 11
Open Access Systematic Review
Various facets of excitotoxicity
Aim: Excitotoxicity results from unusually increased activation of excitatory amino acid receptors leading to neuronal death. Since glutamate is the main excitatory neurotransmitter in the centra
Published: February 23, 2022 Explor Neuroprot Ther. 2022;2:36–64
8886 200 6
Open Access Perspective
Gut microbiota could modulate the effects of neuro-immune responses and memory traces via the gut-brain-immune axis in schizophrenia
Altered immunity may have destructive consequences for the integrated central nervous system. This immune response often affects progressive neurodegenerative diseases such as Parkinson’s disease and/or psychiatric disorders such as schizophrenia. In particular, schizophrenia pathogenesis may be mediated by multiple neuro-immune interaction pathways. Gut microbiota might affect the brain and/or immune function. Significant machineries of immunity are commonly affected by the commensal gut microbiota. Therefore, schizophrenia may be connected with the gut-immune system. In addition, the brain and immune systems cooperate on multiple levels. The brain could save several pieces of information about specific inflammation in a body. This immunological memory named “engrams”, also called memory traces, could restore the initial disease state, which may help to explain key features of schizophrenia. Based on this concept, therapeutic strategies for schizophrenia could be the modification of the gut microbiota. Probiotics and/or fecal microbiota transplantation are now emerging as the most promising treatments for the modification. More consideration of the roles of gut microbiota will conduct the further development of immune-based therapeutics for the prevention and/or treatments of psychiatric disorders.
Published: April 24, 2022 Explor Neuroprot Ther. 2022;2:74–86
8175 2197 5
Open Access Review
Balancing cholesterol in the brain: from synthesis to disposal
The cholesterol is a vital component of cell membranes and myelin sheaths, and a precursor for essential molecules such as steroid hormones. In humans, cholesterol is partially obtained through the
Published: January 05, 2022 Explor Neuroprot Ther. 2022;2:1–27
12803 446 11
Open Access Review
Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Phosphoinositides are membrane phospholipids involved in a variety of cellular processes like growth, development, metabolism, and transport. This review focuses on the maintenance of cellular homeo
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86–110
10252 329 30
Open Access Review
Neurological complications during HIV infection
Early in the course of infection, human immunodeficiency virus (HIV) is able to enter the central nervous system where it stablishes a permanent reservoir. Current antiretroviral therapies do not ef
Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:19–32
7732 274 1
Open Access Review
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting 1% of the population above sixty years. It is caused by an interaction between genetic and envi
Published: February 27, 2023 Explor Neuroprot Ther. 2023;3:24–46
9707 247 11
Open Access Review
Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry
Since the identification and cloning of the cannabinoid receptor 2 (CB2R), several studies focused on the characterization of its physiological and pathological role. Initially, CB2R was considered
Published: August 05, 2021 Explor Neuroprot Ther. 2021;1:55–71
5859 220 3
Open Access Review
Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Phosphoinositides are membrane phospholipids involved in a variety of cellular processes like growth, development, metabolism, and transport. This review focuses on the maintenance of cellular homeo
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86–110
10252 329 30
Open Access Review
Blocking cholesterol storage to treat Alzheimer’s disease
Cholesterol serves as an essential lipid molecule in various membrane organelles of mammalian cells. The metabolites of cholesterol also play important functions. Acyl-coenzyme A: cholesterol acyltr
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:173–184
4606 109 18
Open Access Review
Advancing diagnosis and treatment of Niemann-Pick C disease through biomarker discovery
Niemann-Pick C disease is a rare neurodegenerative, lysosomal storage disease caused by accumulation of unesterified cholesterol. Diagnosis of the disease is often delayed due to its rarity, the het
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:146–158
3794 98 17
Open Access Review
Subarachnoid hemorrhage: management considerations for COVID-19
Subarachnoid hemorrhage (SAH) has deleterious outcomes for patients, and during the hospital stay, patients are susceptible to vasospasm and delayed cerebral ischemia. Coronavirus disease 2019 (COVI
Published: March 02, 2022 Explor Neuroprot Ther. 2022;2:65–73
5707 67 15
Open Access Review
Balancing cholesterol in the brain: from synthesis to disposal
The cholesterol is a vital component of cell membranes and myelin sheaths, and a precursor for essential molecules such as steroid hormones. In humans, cholesterol is partially obtained through the
Published: January 05, 2022 Explor Neuroprot Ther. 2022;2:1–27
12803 446 11
Open Access Review
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting 1% of the population above sixty years. It is caused by an interaction between genetic and envi
Published: February 27, 2023 Explor Neuroprot Ther. 2023;3:24–46
9707 247 11

Special Issues

Ongoing Special lssues
Completed Special lssues
Breakthroughs in Mechanisms and Treatments for Neurodegenerative Diseases
Dr. Rong Ma Dr. Guoku Hu
August 31, 2025
Published Articles: 0
Advances in the Pathogenesis, Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder
Dr. Michele Roccella Dr. Luigi Vetri
September 30, 2025
Published Articles: 1
Interdisciplinary Approach to Therapeutic Strategies of Neuroprotection in Present and Future
Prof. Athanasios K. Petridis
October 05, 2025
Published Articles: 1
Marine Plant Natural Products for Neuroprotection
Prof. Leonel Pereira
September 30, 2025
Published Articles: 0
GPCR Heteroreceptor Complexes as Key Players in Neuroprotection
Dr. Dasiel O. Borroto Escuela
August 31, 2025
Published Articles: 4
Defending the Brain and the Mind: Exploring Neuroprotective Therapies for Mental Health Disorders
Dr. Masaru Tanaka
March 31, 2025
Published Articles: 2
Neuro-Inflammation as a Target in the Design of Multifunctional Drug Candidates for Neurodegenerative Diseases
Prof. Claudio Viegas Jr. Prof. Arthur Eugen Kümmerle Prof. Vanessa Silva Gontijo
May 31, 2025
Published Articles: 2
Therapeutic Targets for Neuroprotection in Ischemic Stroke
Dr. Silvia Fischer
August 31, 2025
Published Articles: 4
Empower Yourself - Physical Activity as Prevention and Rehabilitation of Neurological and Psychiatric Diseases
Dr. Manuel Zeitelhofer
September 30, 2025
Published Articles: 2
Natural Products in Neurotherapeutic Applications
Prof. Marcello Iriti
September 30, 2025
Published Articles: 2
New Advances in Imaging Techniques for the Evaluation of Neurological Disorders
Prof. Valery V. Tuchin
September 30, 2025
Published Articles: 1
Role of the Monoaminergic Systems in the Pathogenesis and the Pathophysiology of Parkinson's Disease
Dr. Abdelhamid Benazzouz
August 30, 2025
Published Articles: 3
Parkinson's Disease: Principal Targets and Interventional Mechanisms
Prof. Mahesh Narayan
August 30, 2025
Published Articles: 4

Focus

Emerging Indications for Botulinum Toxin Treatment
Prof. Lucio Marinelli
Jul. 14, 2023 2034

Membership

Journal Indexing
Journal Metrics
Article Usage (total)

Views: 367,174

Downloads: 10,447

Follow the Journal